Life Sciences and Public Health Preparedness
Life Sciences and Public Health Preparedness is a multi-faceted resource for the biotechnology sector, including experience in emerging infectious diseases, biodefense, pandemic influenza preparedness, detection and diagnostic technologies, decision support systems for public health response, industrial biotechnology, and the burgeoning clean-tech sector.
McKenna Long & Aldridge (MLA) helps clients exceed their business objectives by developing and executing agreements for funding for technological advancements in the life sciences that allow companies to create profitable partnerships across the pharmaceutical, biotechnology, defense technology, and clean-tech industries. Equally as important, we help the financial community understand the opportunities and challenges of working with the federal government, and how to leverage government funding or government policy to maximize an investment decision.
The Life Sciences and Public Health Preparedness team boasts well-respected professionals with a range of legal, political, governmental, scientific and business planning experience. We help secure government contracts, grants, and collaborations for technology offerings across the public health and life science sector as a result of access to political leaders, federal agency managers, scientific entrepreneurs, and company leaders who are spearheading life sciences advancements. Members of our team work to provide strategic government affairs and business counseling, as well as due diligence reviews for investors and other entities considering joining this quickly expanding sector. MLA provides substantive value for clients regarding all public policy issues and impending legislation in the fields of biotechnology and life sciences.
The Life Sciences and Public Health Preparedness team is ready with authoritative advice on creating new markets for biotechnology companies interested in government funding from the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), the Department of Homeland Security (DHS), the Department of Defense (DOD), the Department of Energy (DOE), the Department of Agriculture (USDA), and others. In addition, our international team is skilled at dealing with various defense and health ministries throughout Europe, and non-government purchasers around the globe. Political intelligence, research and access to important decision makers is key to understanding how biotech companies can thrive.
MLA’s Life Sciences and Public Health Preparedness practice’s provides advisory services in the following arenas:
- Public Health Preparedness
- Biodefense
- Pandemic Influenza Preparedness
- Detection and Diagnostics
- Emerging Infectious Disease
- Industrial Biotechnology
- Biofuels
- Environmental Biotechnology
- Government Affairs
- Legislative Action
- Science
- Venture Capital and Private Equity
- Health Care
- Compliance
Advisories
News
- Maximizing the Use of Project BioShield Contracting
- Flu Vaccine: Drugmakers Could Be Ready Soon
- Glaxo, Roche Meet Swine-Flu Drug Needs; Vaccine Is Months Away